• Single-Base Resolution Mapping of 5hmC in Rice Drought Respo

  2026-07-31

  This study delivers the first single-base resolution map of 5-hydroxymethylcytosine (5hmC) in rice, illuminating its context-dependent roles in gene regulation during drought stress. By integrating advanced sequencing approaches, the research uncovers dynamic, antagonistic interactions between 5hmC and 5mC, revealing new mechanistic insights into epigenetic adaptation in plants.

• K+ Channel Blockade and Renal Blood Flow in Septic Rats: Ins

  2026-07-31

  This study uncovers how blocking ATP-sensitive (Kir6.1) and calcium-activated (KCa1.1) potassium channels in septic rats alters renal vascular responses to norepinephrine and phenylephrine, leading to worsened reductions in renal blood flow. The findings offer mechanistic insight for researchers investigating vasodilation pathways and kidney dysfunction in sepsis models.

• β-Pseudouridine: Enhancing RNA Modification and Vaccine Prec

  2026-07-30

  β-Pseudouridine, the C-glycoside isomer of uridine, is reshaping RNA research by stabilizing RNA structures and enabling dose-sparing, highly immunogenic vaccines. This guide distills current reference breakthroughs into actionable protocols, troubleshooting strategies, and advanced workflow advantages for next-generation epitranscriptomic and mRNA vaccine applications.

• FGFR1 Regulates Early Human Adipogenesis: Insights from PD 1

  2026-07-30

  This study establishes fibroblast growth factor receptor 1 (FGFR1) as a pivotal regulator of early adipogenic commitment and proliferation in human preadipocytes. Using both pharmacological inhibition and genetic knockdown, the research clarifies that FGFR1 activity is uniquely essential for priming and differentiating preadipocytes, informing potential strategies for obesity interventions.

• CGP 55845 Hydrochloride: Advancing GABAB Antagonist Research

  2026-07-29

  Explore the in-depth mechanisms and new frontiers of CGP 55845 hydrochloride as a GABAB receptor antagonist. This article uniquely bridges astrocytic GAT-3 innovation with practical assay strategy, offering scientists fresh insights beyond standard protocols.

• Prednisolone in Synthetic Glucocorticoid Research: Protocols

  2026-07-29

  Prednisolone, a synthetic glucocorticoid, is driving new frontiers in glucocorticoid signaling and immunology research, especially in studies of inflammation modulation and ERAD-mediated protein degradation. Explore advanced workflows, troubleshooting insights, and protocol parameters to maximize the impact of APExBIO’s ultra-pure Prednisolone in your experimental designs.

• Metal-Ion-Chelating l-Phe Nanostructures Enhance ICB Immunit

  2026-07-28

  This study reveals that metal-ion-chelating l-phenylalanine nanostructures, when paired with short-term starvation, remodel the tumor microenvironment and potentiate immune checkpoint blockade in breast cancer. The approach leverages dendritic cell ion channel modulation to reverse immune dysfunction, offering a mechanistically novel route to improve immunotherapy responsiveness.

• Dihydrotestosterone (DHT): Molecular Insights for Cancer and

  2026-07-28

  Explore the molecular role of Dihydrotestosterone (DHT) in cancer signaling and neurodegenerative disease models. This in-depth analysis reveals unique mechanistic insights and protocol guidance for advanced research applications.

• NVP-BGJ398 Phosphate: Protocols for FGFR Inhibition in Disea

  2026-07-27

  NVP-BGJ398 phosphate stands out as a pan-FGFR inhibitor, enabling precision targeting of FGFR-driven pathways in both cancer and skeletal disease research. This article details applied workflows, troubleshooting, and experimental insights for maximizing reproducibility in FGFR signaling studies.

• 3X (DYKDDDDK) Peptide: Transforming FLAG Tag Protein Workflo

  2026-07-27

  The 3X (DYKDDDDK) Peptide from APExBIO sets a new standard for affinity purification and immunodetection of FLAG-tagged proteins, excelling even in demanding structural biology and metal-sensitive assay contexts. Discover its protocol-enhancing properties, practical troubleshooting tips, and integration with cutting-edge research on membrane protein complexes.

• Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X

  2026-07-26

  The Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O) is designed to prevent protein degradation and dephosphorylation during extraction from diverse biological samples. It is particularly suited for workflows where EDTA-induced metal chelation is undesirable, such as studies involving metalloproteins. This product should not be used where chelation-based inhibition is required.

• Reliable Phenacetin Workflows: SKU B1453 in Pharmacokinetic

  2026-07-25

  This article delivers evidence-backed best practices for integrating Phenacetin (SKU B1453) into cell-based pharmacokinetic studies. Drawing on recent organoid research, workflow compatibility, and vendor reliability, it demonstrates how APExBIO's Phenacetin supports reproducible, sensitive assays in modern biomedical laboratories.

• Regorafenib Suppresses Melanoma via RRM2 Downregulation Mech

  2026-07-24

  A recent iScience study revealed that Regorafenib (BAY 73-4506) inhibits melanoma progression by decreasing RRM2 expression, leading to reduced cell proliferation, invasion, and metastasis. This mechanistic insight highlights the ERK/E2F3-RRM2 axis as a promising target for advancing melanoma research and therapeutic strategies.

• Isoprenaline Hydrochloride in Heart–Brain Axis and β-Adrener

  2026-07-24

  Explore the multifaceted applications of Isoprenaline Hydrochloride in both cardiac and neurobehavioral research. This article uniquely examines β-adrenergic signaling in heart–brain axis models, integrating new mechanistic insights and assay guidance for advanced researchers.

• SR-202: Strategic PPARγ Antagonism for Translational Metabol

  2026-07-23

  Explore how SR-202, a selective PPARγ antagonist from APExBIO, empowers translational researchers to dissect the immunometabolic nexus of obesity, diabetes, and inflammation. This article integrates mechanistic insight, experimental best practices, and strategic context, bridging recent macrophage polarization discoveries with actionable guidance for next-generation drug development.

444 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page